Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-007852
Filing Date
2025-01-22
Accepted
2025-01-22 17:04:41
Documents
1
Period of Report
2025-01-17

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3308
  Complete submission text file 0000950170-25-007852.txt   4710
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Issuer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
Shetzline Michael (Reporting) CIK: 0001808509 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34620 | Film No.: 25546674